Accessibility links
Drugmaker's New AIDS Drug Strategy The big drugmaker Pharmacia will allow generic versions of its AIDS drug Rescriptor to be sold in poor countries. But only in poor countries. In a new approach to AIDS treatment, Pharmacia says generic manufacturers can make copies of its drug, but in a different shape and color. The company hopes that distinction would make it difficult for illegal shipments of the generic versions to be sold on the black market in the U.S. and other wealthy countries. NPR's Snigdha Prakash reports.

Drugmaker's New AIDS Drug Strategy

Heard on All Things Considered

Drugmaker's New AIDS Drug Strategy

Listen · 3:24
  • Download
  • <iframe src="https://www.npr.org/player/embed/936744/936745" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

The big drugmaker Pharmacia will allow generic versions of its AIDS drug Rescriptor to be sold in poor countries. But only in poor countries. In a new approach to AIDS treatment, Pharmacia says generic manufacturers can make copies of its drug, but in a different shape and color. The company hopes that distinction would make it difficult for illegal shipments of the generic versions to be sold on the black market in the U.S. and other wealthy countries. NPR's Snigdha Prakash reports.

Copyright © 2003 NPR. All rights reserved. Visit our website terms of use and permissions pages at www.npr.org for further information.

NPR transcripts are created on a rush deadline by an NPR contractor. This text may not be in its final form and may be updated or revised in the future. Accuracy and availability may vary. The authoritative record of NPR’s programming is the audio record.